APO Research
Talk to an analyst

APO RESEARCH · REPORT

DH5α Competent Cells

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DH5α Competent Cells Market Outlook and Growth Opportunities 2026

26 December 2025207 pages

Choose your research edition.

Industry ResearchDH5α Competent Cells Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal DH5α Competent Cells Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal DH5α Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DH5α Competent Cells Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal DH5α Competent Cells Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global DH5α Competent Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DH5α Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DH5α Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DH5α Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DH5α Competent Cells market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DH5α Competent Cells market include ZOMANBIO, Yeasen, NCM Biotech, TIANGEN, Thermo Fisher Scientific, Merck, Maokangbio, Beyotime and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DH5α Competent Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DH5α Competent Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DH5α Competent Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DH5α Competent Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

DH5α Competent Cells Segment by Company

ZOMANBIO

Yeasen

NCM Biotech

TIANGEN

Thermo Fisher Scientific

Merck

Maokangbio

Beyotime

Zymo Research

Takara Bio

Promega Corporation

New England Biolabs (NEB)

LGC Biosearch Technologies

GenScript

Bio-Rad

Addgene

DH5α Competent Cells Segment by Type

Chemically Competent DH5α Cells

Electrocompetent DH5α Cells

DH5α Competent Cells Segment by Application

Cloning

Proteomics

DH5α Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DH5α Competent Cells status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions DH5α Competent Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DH5α Competent Cells significant trends, drivers, influence factors in global and regions.

6. To analyze DH5α Competent Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DH5α Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DH5α Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DH5α Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DH5α Competent Cells market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DH5α Competent Cells industry.

Chapter 3: Detailed analysis of DH5α Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of DH5α Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of DH5α Competent Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DH5α Competent Cells Industry Trends Table 2. DH5α Competent Cells Industry Drivers Table 3. DH5α Competent Cells Industry Opportunities and Challenges Table 4. DH5α Competent Cells Industry Restraints Table 5. Global DH5α Competent Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DH5α Competent Cells Revenue Share by Company (2021-2026) Table 7. Global DH5α Competent Cells Sales Volume by Company (K Units) & (2021-2026) Table 8. Global DH5α Competent Cells Sales Volume Share by Company (2021-2026) Table 9. Global DH5α Competent Cells Average Price (US$/Unit) of Company (2021-2026) Table 10. Global DH5α Competent Cells Company Ranking, (2024-2026) & (USD Million) Table 11. Global DH5α Competent Cells Key Company Manufacturing Base & Headquarters Table 12. Global DH5α Competent Cells Company, Product Type & Application Table 13. Global DH5α Competent Cells Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global DH5α Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Chemically Competent DH5α Cells Table 18. Significant Companies of Electrocompetent DH5α Cells Table 19. Global DH5α Competent Cells Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global DH5α Competent Cells Sales Volume by Type (2021-2026) & (K Units) Table 21. Global DH5α Competent Cells Sales Volume by Type (2027-2032) & (K Units) Table 22. Global DH5α Competent Cells Sales Volume Share by Type (2021-2026) Table 23. Global DH5α Competent Cells Sales Volume Share by Type (2027-2032) Table 24. Global DH5α Competent Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global DH5α Competent Cells Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global DH5α Competent Cells Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global DH5α Competent Cells Sales Value Share by Type (2021-2026) Table 28. Global DH5α Competent Cells Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cloning Table 30. Significant Companies of Proteomics Table 31. Global DH5α Competent Cells Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global DH5α Competent Cells Sales Volume by Application (2021-2026) & (K Units) Table 33. Global DH5α Competent Cells Sales Volume by Application (2027-2032) & (K Units) Table 34. Global DH5α Competent Cells Sales Volume Share by Application (2021-2026) Table 35. Global DH5α Competent Cells Sales Volume Share by Application (2027-2032) Table 36. Global DH5α Competent Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global DH5α Competent Cells Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global DH5α Competent Cells Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global DH5α Competent Cells Sales Value Share by Application (2021-2026) Table 40. Global DH5α Competent Cells Sales Value Share by Application (2027-2032) Table 41. Global DH5α Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global DH5α Competent Cells Sales by Region (2021-2026) & (K Units) Table 43. Global DH5α Competent Cells Sales Market Share by Region (2021-2026) Table 44. Global DH5α Competent Cells Sales by Region (2027-2032) & (K Units) Table 45. Global DH5α Competent Cells Sales Market Share by Region (2027-2032) Table 46. Global DH5α Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global DH5α Competent Cells Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global DH5α Competent Cells Sales Value Share by Region (2021-2026) Table 49. Global DH5α Competent Cells Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global DH5α Competent Cells Sales Value Share by Region (2027-2032) Table 51. Global DH5α Competent Cells Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global DH5α Competent Cells Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global DH5α Competent Cells Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global DH5α Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global DH5α Competent Cells Sales by Country (2021-2026) & (K Units) Table 56. Global DH5α Competent Cells Sales Market Share by Country (2021-2026) Table 57. Global DH5α Competent Cells Sales by Country (2027-2032) & (K Units) Table 58. Global DH5α Competent Cells Sales Market Share by Country (2027-2032) Table 59. Global DH5α Competent Cells Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global DH5α Competent Cells Sales Value Market Share by Country (2021-2026) Table 61. Global DH5α Competent Cells Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global DH5α Competent Cells Sales Value Market Share by Country (2027-2032) Table 63. ZOMANBIO Company Information Table 64. ZOMANBIO Business Overview Table 65. ZOMANBIO DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. ZOMANBIO DH5α Competent Cells Product Portfolio Table 67. ZOMANBIO Recent Development Table 68. Yeasen Company Information Table 69. Yeasen Business Overview Table 70. Yeasen DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Yeasen DH5α Competent Cells Product Portfolio Table 72. Yeasen Recent Development Table 73. NCM Biotech Company Information Table 74. NCM Biotech Business Overview Table 75. NCM Biotech DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. NCM Biotech DH5α Competent Cells Product Portfolio Table 77. NCM Biotech Recent Development Table 78. TIANGEN Company Information Table 79. TIANGEN Business Overview Table 80. TIANGEN DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. TIANGEN DH5α Competent Cells Product Portfolio Table 82. TIANGEN Recent Development Table 83. Thermo Fisher Scientific Company Information Table 84. Thermo Fisher Scientific Business Overview Table 85. Thermo Fisher Scientific DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Thermo Fisher Scientific DH5α Competent Cells Product Portfolio Table 87. Thermo Fisher Scientific Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Merck DH5α Competent Cells Product Portfolio Table 92. Merck Recent Development Table 93. Maokangbio Company Information Table 94. Maokangbio Business Overview Table 95. Maokangbio DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Maokangbio DH5α Competent Cells Product Portfolio Table 97. Maokangbio Recent Development Table 98. Beyotime Company Information Table 99. Beyotime Business Overview Table 100. Beyotime DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Beyotime DH5α Competent Cells Product Portfolio Table 102. Beyotime Recent Development Table 103. Zymo Research Company Information Table 104. Zymo Research Business Overview Table 105. Zymo Research DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Zymo Research DH5α Competent Cells Product Portfolio Table 107. Zymo Research Recent Development Table 108. Takara Bio Company Information Table 109. Takara Bio Business Overview Table 110. Takara Bio DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Takara Bio DH5α Competent Cells Product Portfolio Table 112. Takara Bio Recent Development Table 113. Promega Corporation Company Information Table 114. Promega Corporation Business Overview Table 115. Promega Corporation DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Promega Corporation DH5α Competent Cells Product Portfolio Table 117. Promega Corporation Recent Development Table 118. New England Biolabs (NEB) Company Information Table 119. New England Biolabs (NEB) Business Overview Table 120. New England Biolabs (NEB) DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. New England Biolabs (NEB) DH5α Competent Cells Product Portfolio Table 122. New England Biolabs (NEB) Recent Development Table 123. LGC Biosearch Technologies Company Information Table 124. LGC Biosearch Technologies Business Overview Table 125. LGC Biosearch Technologies DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. LGC Biosearch Technologies DH5α Competent Cells Product Portfolio Table 127. LGC Biosearch Technologies Recent Development Table 128. GenScript Company Information Table 129. GenScript Business Overview Table 130. GenScript DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. GenScript DH5α Competent Cells Product Portfolio Table 132. GenScript Recent Development Table 133. Bio-Rad Company Information Table 134. Bio-Rad Business Overview Table 135. Bio-Rad DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Bio-Rad DH5α Competent Cells Product Portfolio Table 137. Bio-Rad Recent Development Table 138. Addgene Company Information Table 139. Addgene Business Overview Table 140. Addgene DH5α Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Addgene DH5α Competent Cells Product Portfolio Table 142. Addgene Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. DH5α Competent Cells Distributors List Table 146. DH5α Competent Cells Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. DH5α Competent Cells Product Image Figure 2. Global DH5α Competent Cells Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DH5α Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 4. Global DH5α Competent Cells Sales (2021-2032) & (K Units) Figure 5. Global DH5α Competent Cells Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global DH5α Competent Cells Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Chemically Competent DH5α Cells Image Figure 10. Electrocompetent DH5α Cells Image Figure 11. Global DH5α Competent Cells Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global DH5α Competent Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global DH5α Competent Cells Sales Volume Share by Type (2021-2032) Figure 14. Global DH5α Competent Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global DH5α Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global DH5α Competent Cells Sales Value Share by Type (2021-2032) Figure 17. Cloning Image Figure 18. Proteomics Image Figure 19. Global DH5α Competent Cells Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global DH5α Competent Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global DH5α Competent Cells Sales Volume Share by Application (2021-2032) Figure 22. Global DH5α Competent Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global DH5α Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global DH5α Competent Cells Sales Value Share by Application (2021-2032) Figure 25. Global DH5α Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global DH5α Competent Cells Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global DH5α Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global DH5α Competent Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America DH5α Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 30. North America DH5α Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe DH5α Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 32. Europe DH5α Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific DH5α Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific DH5α Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America DH5α Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 36. South America DH5α Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa DH5α Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa DH5α Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt DH5α Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. DH5α Competent Cells Value Chain Figure 124. Manufacturing Cost Structure Figure 125. DH5α Competent Cells Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent DH5α Cells
  • Electrocompetent DH5α Cells
Applications
  • Cloning
  • Proteomics
Companies covered
  • ZOMANBIO
  • Yeasen
  • NCM Biotech
  • TIANGEN
  • Thermo Fisher Scientific
  • Merck
  • Maokangbio
  • Beyotime
  • Zymo Research
  • Takara Bio
  • Promega Corporation
  • New England Biolabs (NEB)
  • LGC Biosearch Technologies
  • GenScript
  • Bio-Rad
  • Addgene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DH5α Competent Cells Sales Value (2021-2032)
  4. 1.2.2 Global DH5α Competent Cells Sales Volume (2021-2032)
  5. 1.2.3 Global DH5α Competent Cells Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 DH5α Competent Cells Market Dynamics
  1. 2.1 DH5α Competent Cells Industry Trends
  2. 2.2 DH5α Competent Cells Industry Drivers
  3. 2.3 DH5α Competent Cells Industry Opportunities and Challenges
  4. 2.4 DH5α Competent Cells Industry Restraints
3 DH5α Competent Cells Market by Company
  1. 3.1 Global DH5α Competent Cells Company Revenue Ranking in 2025
  2. 3.2 Global DH5α Competent Cells Revenue by Company (2021-2026)
  3. 3.3 Global DH5α Competent Cells Sales Volume by Company (2021-2026)
  4. 3.4 Global DH5α Competent Cells Average Price by Company (2021-2026)
  5. 3.5 Global DH5α Competent Cells Company Ranking (2024-2026)
  6. 3.6 Global DH5α Competent Cells Company Manufacturing Base and Headquarters
  7. 3.7 Global DH5α Competent Cells Company Product Type and Application
  8. 3.8 Global DH5α Competent Cells Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global DH5α Competent Cells Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 DH5α Competent Cells Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 DH5α Competent Cells Market by Type
  1. 4.1 DH5α Competent Cells Type Introduction
  2. 4.1.1 Chemically Competent DH5α Cells
  3. 4.1.2 Electrocompetent DH5α Cells
  4. 4.2 Global DH5α Competent Cells Sales Volume by Type
  5. 4.2.1 Global DH5α Competent Cells Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DH5α Competent Cells Sales Volume by Type (2021-2032)
  7. 4.2.3 Global DH5α Competent Cells Sales Volume Share by Type (2021-2032)
  8. 4.3 Global DH5α Competent Cells Sales Value by Type
  9. 4.3.1 Global DH5α Competent Cells Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global DH5α Competent Cells Sales Value by Type (2021-2032)
  11. 4.3.3 Global DH5α Competent Cells Sales Value Share by Type (2021-2032)
5 DH5α Competent Cells Market by Application
  1. 5.1 DH5α Competent Cells Application Introduction
  2. 5.1.1 Cloning
  3. 5.1.2 Proteomics
  4. 5.2 Global DH5α Competent Cells Sales Volume by Application
  5. 5.2.1 Global DH5α Competent Cells Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DH5α Competent Cells Sales Volume by Application (2021-2032)
  7. 5.2.3 Global DH5α Competent Cells Sales Volume Share by Application (2021-2032)
  8. 5.3 Global DH5α Competent Cells Sales Value by Application
  9. 5.3.1 Global DH5α Competent Cells Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DH5α Competent Cells Sales Value by Application (2021-2032)
  11. 5.3.3 Global DH5α Competent Cells Sales Value Share by Application (2021-2032)
6 DH5α Competent Cells Regional Sales and Value Analysis
  1. 6.1 Global DH5α Competent Cells Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DH5α Competent Cells Sales by Region (2021-2032)
  3. 6.2.1 Global DH5α Competent Cells Sales by Region: 2021-2026
  4. 6.2.2 Global DH5α Competent Cells Sales by Region (2027-2032)
  5. 6.3 Global DH5α Competent Cells Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global DH5α Competent Cells Sales Value by Region (2021-2032)
  7. 6.4.1 Global DH5α Competent Cells Sales Value by Region: 2021-2026
  8. 6.4.2 Global DH5α Competent Cells Sales Value by Region (2027-2032)
  9. 6.5 Global DH5α Competent Cells Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America DH5α Competent Cells Sales Value (2021-2032)
  12. 6.6.2 North America DH5α Competent Cells Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe DH5α Competent Cells Sales Value (2021-2032)
  15. 6.7.2 Europe DH5α Competent Cells Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific DH5α Competent Cells Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific DH5α Competent Cells Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America DH5α Competent Cells Sales Value (2021-2032)
  21. 6.9.2 South America DH5α Competent Cells Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa DH5α Competent Cells Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa DH5α Competent Cells Sales Value Share by Country, 2025 VS 2032
7 DH5α Competent Cells Country-level Sales and Value Analysis
  1. 7.1 Global DH5α Competent Cells Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DH5α Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global DH5α Competent Cells Sales by Country (2021-2032)
  4. 7.3.1 Global DH5α Competent Cells Sales by Country (2021-2026)
  5. 7.3.2 Global DH5α Competent Cells Sales by Country (2027-2032)
  6. 7.4 Global DH5α Competent Cells Sales Value by Country (2021-2032)
  7. 7.4.1 Global DH5α Competent Cells Sales Value by Country (2021-2026)
  8. 7.4.2 Global DH5α Competent Cells Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt DH5α Competent Cells Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt DH5α Competent Cells Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt DH5α Competent Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ZOMANBIO
  2. 8.1.1 ZOMANBIO Company Information
  3. 8.1.2 ZOMANBIO Business Overview
  4. 8.1.3 ZOMANBIO DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ZOMANBIO DH5α Competent Cells Product Portfolio
  6. 8.1.5 ZOMANBIO Recent Developments
  7. 8.2 Yeasen
  8. 8.2.1 Yeasen Company Information
  9. 8.2.2 Yeasen Business Overview
  10. 8.2.3 Yeasen DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yeasen DH5α Competent Cells Product Portfolio
  12. 8.2.5 Yeasen Recent Developments
  13. 8.3 NCM Biotech
  14. 8.3.1 NCM Biotech Company Information
  15. 8.3.2 NCM Biotech Business Overview
  16. 8.3.3 NCM Biotech DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NCM Biotech DH5α Competent Cells Product Portfolio
  18. 8.3.5 NCM Biotech Recent Developments
  19. 8.4 TIANGEN
  20. 8.4.1 TIANGEN Company Information
  21. 8.4.2 TIANGEN Business Overview
  22. 8.4.3 TIANGEN DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TIANGEN DH5α Competent Cells Product Portfolio
  24. 8.4.5 TIANGEN Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific DH5α Competent Cells Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck DH5α Competent Cells Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Maokangbio
  38. 8.7.1 Maokangbio Company Information
  39. 8.7.2 Maokangbio Business Overview
  40. 8.7.3 Maokangbio DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Maokangbio DH5α Competent Cells Product Portfolio
  42. 8.7.5 Maokangbio Recent Developments
  43. 8.8 Beyotime
  44. 8.8.1 Beyotime Company Information
  45. 8.8.2 Beyotime Business Overview
  46. 8.8.3 Beyotime DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beyotime DH5α Competent Cells Product Portfolio
  48. 8.8.5 Beyotime Recent Developments
  49. 8.9 Zymo Research
  50. 8.9.1 Zymo Research Company Information
  51. 8.9.2 Zymo Research Business Overview
  52. 8.9.3 Zymo Research DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zymo Research DH5α Competent Cells Product Portfolio
  54. 8.9.5 Zymo Research Recent Developments
  55. 8.10 Takara Bio
  56. 8.10.1 Takara Bio Company Information
  57. 8.10.2 Takara Bio Business Overview
  58. 8.10.3 Takara Bio DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Takara Bio DH5α Competent Cells Product Portfolio
  60. 8.10.5 Takara Bio Recent Developments
  61. 8.11 Promega Corporation
  62. 8.11.1 Promega Corporation Company Information
  63. 8.11.2 Promega Corporation Business Overview
  64. 8.11.3 Promega Corporation DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Promega Corporation DH5α Competent Cells Product Portfolio
  66. 8.11.5 Promega Corporation Recent Developments
  67. 8.12 New England Biolabs (NEB)
  68. 8.12.1 New England Biolabs (NEB) Company Information
  69. 8.12.2 New England Biolabs (NEB) Business Overview
  70. 8.12.3 New England Biolabs (NEB) DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 New England Biolabs (NEB) DH5α Competent Cells Product Portfolio
  72. 8.12.5 New England Biolabs (NEB) Recent Developments
  73. 8.13 LGC Biosearch Technologies
  74. 8.13.1 LGC Biosearch Technologies Company Information
  75. 8.13.2 LGC Biosearch Technologies Business Overview
  76. 8.13.3 LGC Biosearch Technologies DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 LGC Biosearch Technologies DH5α Competent Cells Product Portfolio
  78. 8.13.5 LGC Biosearch Technologies Recent Developments
  79. 8.14 GenScript
  80. 8.14.1 GenScript Company Information
  81. 8.14.2 GenScript Business Overview
  82. 8.14.3 GenScript DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 GenScript DH5α Competent Cells Product Portfolio
  84. 8.14.5 GenScript Recent Developments
  85. 8.15 Bio-Rad
  86. 8.15.1 Bio-Rad Company Information
  87. 8.15.2 Bio-Rad Business Overview
  88. 8.15.3 Bio-Rad DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bio-Rad DH5α Competent Cells Product Portfolio
  90. 8.15.5 Bio-Rad Recent Developments
  91. 8.16 Addgene
  92. 8.16.1 Addgene Company Information
  93. 8.16.2 Addgene Business Overview
  94. 8.16.3 Addgene DH5α Competent Cells Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Addgene DH5α Competent Cells Product Portfolio
  96. 8.16.5 Addgene Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DH5α Competent Cells Value Chain Analysis
  2. 9.1.1 DH5α Competent Cells Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DH5α Competent Cells Sales Mode & Process
  6. 9.2 DH5α Competent Cells Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DH5α Competent Cells Distributors
  9. 9.2.3 DH5α Competent Cells Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst